RS Investment Management
PBYI icon

RS Investment Management’s Puma Biotechnology PBYI Stock Holding History

RS Investment Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-92,188
Closed -$22M – 386
2014
Q3 		$22M Buy
+92,188
New +$18.9M 0.2% 161

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BB Biotech
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RS Investment Management's PBYI Position: Q4 2014 in Review

RS Investment Management sold out of Puma Biotechnology (PBYI) in Q4 2014, closing a stake of 92,188 shares — an estimated $22M sold.

RS Investment Management first reported a position in PBYI in Q3 2014 and held it in 1 quarter. The position peaked at $22M in Q3 2014. 189 funds tracked by Wall St. Rank hold PBYI as of Q4 2014.

  • RS Investment Management reported no remaining Puma Biotechnology position as of Q4 2014 after selling out during the quarter.
  • RS Investment Management sold 92,188 Puma Biotechnology shares in Q4 2014, an estimated $22M.
  • RS Investment Management first reported a position in Puma Biotechnology in Q3 2014 and held it in 1 quarter.
  • RS Investment Management's Puma Biotechnology position peaked at $22M in Q3 2014.
  • 189 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2014.

Based on RS Investment Management's 13F filing for Q4 2014, filed 12 Feb 2015.